Patent · US Active

Amyloid β fibrillogenesis-inhibiting peptide

US8697651B2 · kind B2 · utility

0Cited by
3References
19Claims
0Family size

Assignee

Inventor

Key dates

Filing dateDec 16, 2011
Grant dateApr 15, 2014
Priority date
Expiry dateFeb 15, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2821
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a peptide which functions as a mimic peptide of an amyloid β peptide and is capable of inhibiting the fibrillogenesis of an amyloid β peptide. The present invention relates to an 8- to 30-amino acid residue peptide comprising an amino acid sequence represented by the following formula (I): X1-Asp-X2-X3-X4-Pro-X5-X6 (SEQ ID NO: 28) (I), wherein X1 represents a branched chain amino acid, and X2, X3, X4, X5, and X6 are the same or different and each represents an α-amino acid, and to a pharmaceutical composition and an amyloid β fibrillogenesis inhibitor comprising the peptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.